| Outgoing Relation(s) |
| Se-methyl-L-selenocysteine (CHEBI:27812) has role antineoplastic agent (CHEBI:35610) |
| Se-methyl-L-selenocysteine (CHEBI:27812) is a Se-methylselenocysteine (CHEBI:9068) |
| Se-methyl-L-selenocysteine (CHEBI:27812) is a L-selenocysteine derivative (CHEBI:84209) |
| Se-methyl-L-selenocysteine (CHEBI:27812) is a non-proteinogenic L-α-amino acid (CHEBI:83822) |
| Se-methyl-L-selenocysteine (CHEBI:27812) is conjugate acid of Se-methyl-L-selenocysteinate (CHEBI:53126) |
| Se-methyl-L-selenocysteine (CHEBI:27812) is conjugate base of Se-methyl-L-selenocysteinium (CHEBI:53130) |
| Se-methyl-L-selenocysteine (CHEBI:27812) is enantiomer of Se-methyl-D-selenocysteine (CHEBI:53125) |
| Se-methyl-L-selenocysteine (CHEBI:27812) is tautomer of Se-methyl-L-selenocysteine zwitterion (CHEBI:58531) |
| Incoming Relation(s) |
| Se-methyl-L-selenocysteinium (CHEBI:53130) is conjugate acid of Se-methyl-L-selenocysteine (CHEBI:27812) |
| Se-methyl-L-selenocysteinate (CHEBI:53126) is conjugate base of Se-methyl-L-selenocysteine (CHEBI:27812) |
| Se-methyl-D-selenocysteine (CHEBI:53125) is enantiomer of Se-methyl-L-selenocysteine (CHEBI:27812) |
| Se-methyl-L-selenocysteine residue (CHEBI:53134) is substituent group from Se-methyl-L-selenocysteine (CHEBI:27812) |
| Se-methyl-L-selenocysteino group (CHEBI:53140) is substituent group from Se-methyl-L-selenocysteine (CHEBI:27812) |
| Se-methyl-L-selenocysteinyl group (CHEBI:53137) is substituent group from Se-methyl-L-selenocysteine (CHEBI:27812) |
| Se-methyl-L-selenocysteine zwitterion (CHEBI:58531) is tautomer of Se-methyl-L-selenocysteine (CHEBI:27812) |